This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Prior to October 2024, the Advisory Committee on Immunization Practices (ACIP) recommended use of a PCV only for all adults aged 65 years and older, including those aged 19 to 64 years with risk conditions for pneumococcal disease.
2 Vitamin D Immunity Vitamin D is a crucial hormone that supports bone health by facilitating the absorption of calcium and phosphorus, which is obtained mainly from sunlight exposure and food. Vitamin D is an accessible and inexpensive option compared to other drugs used to improve the response to chemotherapy.”
Kevin Sayer, CEO of Dexcom, discusses the key barriers to continuous glucose monitoring (CGM) adoption for type 2 diabetes (T2D) in an interview with Pharmacy Times® at the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago, Illinois.
November is American Diabetes Month – a time to come together to spread awareness about diabetes prevention and management. Pharmacies play a crucial role in healthcare, making them ideal partners in promoting awareness and education during this month.
The dual-target approach of amylin and GLP-1 receptor agonists offers a promising strategy for managing obesity and type 2 diabetes. REDEFINE 1 and 2 trials showed clinically meaningful weight reduction and glycemic improvements, with consistent safety profiles and mild gastrointestinal symptoms as common adverse events.
Receiving CAR T therapy can take several weeks, and though very effective against difficult-to-treat cancers, it can sometimes cause life-threatening adverse events, such as cytokine release syndrome (CRS) or immune effector cell-associated neurotoxicity syndrome (ICANS).
SHOW MORE Steroids hindered the shrinkage of tumors in patients with non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitor (ICI) therapy.
Wick, MBA, RPh, FASCP Key Takeaways Pharmacists can address SDOH by providing patient-centered care, promoting immunizations, and offering point-of-care testing to improve health outcomes. Addressing pharmacy deserts and enhancing interdisciplinary collaboration, especially with social workers, are crucial for improving health care access.
Participants followed a 12-week TDR program with behavioral support, showing non-inferiority in eating disorder symptoms compared to usual care. No new eating disorder diagnoses were reported, and the study suggests TDR programs do not increase eating disorder risks.
So there’s things in the pipeline that are being developed with novel conjugated agents, such as radiopharmaceuticals, immune-activating agents like STING agents, PROTACs. And so, although they’re very effective, they still have a lot of those chemo side effects.
Results Data will include toxicity management in the OP setting (eg, rates and grades of CRS/immune effector cell–associated neurotoxicity syndrome, deferred admissions, etc), an algorithm for appropriately selecting patients for OP administration, and a specific OP SUD treatment protocol.
4 Nononcology applications are growing, however, particularly for conditions such as osteoarthritis, type 1 diabetes, and Parkinson disease. The most targeted cancers include acute myeloid leukemia, liver cancer, and pancreatic cancer.
Pharmacy Times : As immunotherapies expand into the solid tumor space, clinicians are reporting cases of ICANS and CRS. Have you observed these immune-related toxicities in your practice, and if so, how are they being managed? All patients should have immunotherapy first. It was approved last year.
For example, CPAs are especially impactful in managing chronic conditions such as diabetes, heart failure, and rheumatoid arthritis, where pharmacist intervention has been shown to improve outcomes and reduce hospitalizations. Creating disease-specific competency assessments also ensures alignment with evolving standards of care.
The study aimed to evaluate both safety and preliminary efficacy outcomes, with a specific focus on hematologic toxicity, pharmacokinetics, and immune system effects. Patients were trained to self-administer their infusion at home or attend clinic visits 3 times weekly.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content